Critical Role of Regulatory T Cells in the Latency and Stress-Induced Reactivation of HSV-1
Herpes simplex virus 1 (HSV-1) spreads in populations through a latency entry and reactivation cycle. The role of host immune-suppressive factor regulatory T cells (Treg cells) in controlling latency establishment and reactivation is not completely understood. Here, using an HSV-1 ocular infection m...
Gespeichert in:
Veröffentlicht in: | Cell reports (Cambridge) 2018-11, Vol.25 (9), p.2379-2389.e3 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Herpes simplex virus 1 (HSV-1) spreads in populations through a latency entry and reactivation cycle. The role of host immune-suppressive factor regulatory T cells (Treg cells) in controlling latency establishment and reactivation is not completely understood. Here, using an HSV-1 ocular infection murine model, we observe a positive correlation between the level of Treg cells and viral infectivity and demonstrate the requirement for Treg cells in latency establishment. Furthermore, we show that host stress leads to HSV-1 reactivation via increased Treg cell control of CD8+ T cells, permitting viral replication under diminished immune surveillance. Together, we propose that Treg cell regulation may serve as a key target for controlling HSV infection.
[Display omitted]
•Treg cells promote the establishment of HSV-1 latent infection•Treg cells suppress anti-viral CD8+ T cells during establishment of latency•Treg cells induced by stress lead to HSV-1 reactivation from latency•Treg cells suppress CD8+ T cell function and prompt HSV-1 reactivation
Herpes simplex virus 1 (HSV-1) spreads in a population through a latency-reactivation cycle. Yu et al. find that Treg cells play a critical role in both HSV-1 latency and reactivation via suppressing anti-viral CD8+ T cells, suggesting that immune regulation serves as a key target for controlling HSV persistent infection. |
---|---|
ISSN: | 2211-1247 2211-1247 |
DOI: | 10.1016/j.celrep.2018.10.105 |